A phase II study to evaluate the effect of adjuvant chemotherapy using hepatic arterial infusion chemotherapy of 5-fluorouracil plus systemic chemotherapy of gemcitabine after resection of pancreatic cancer
Phase 2
- Conditions
- resectable pancreatic cancer
- Registration Number
- JPRN-UMIN000000549
- Lead Sponsor
- ara Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
1) interstitial pneumonia, pulmonary fibrosis 2) intractable pleural effusion 3) intractable diabetes mellitus or liver dysfunction 4) distant metastasis 5) other active cancers 6) apparent infection 7) sever postoperative complications 8) active peptic ulcer 9) episode of myocardial infarction within three months 10) mental disorders 11) pregnacy or patient's hope to be pregnant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method disease-free survival time
- Secondary Outcome Measures
Name Time Method adverse effect, treatment compliance, survival time